Summary
The influence of somatostatin on tumor cell growth was studied in vivo in mice (sarcoma 180 ascites tumor and Lewis lung tumor) and in vitro on nontransformed and polyoma-transformed cell lines. 4 or 20 μg/100 g of cyclic somatostatin and 4 μg/100 g of linear protamin Zn-bound somatostatin were injected s.c. twice daily in the in vivo study. Cyclic somatostatin (1, 4 or 10 μg/ml) was added twice daily to the cell cultures. Somatostatin administration influenced neither the survival of animals nor the growth rate of cultured cell lines. *** DIRECT SUPPORT *** A2025117 00011
Similar content being viewed by others
References
M. T. McQuillan, Somatostatin. Churchill Livingstone, Edinburgh 1977.
H. Wagner, K. Hengst, E. Zierden and U. Gerlach, Metabolism27, suppl. 1, 1381 (1978).
T. Lehy, M. Dubrasquet and S. Bonfils, Digestion19, 99 (1979).
K. H. Tragl and H. Kinast, Klin. Wschr.55, 707 (1977).
K. H. Tragl, H. Kinast, H. Steininger and G. Geyer, Metabolism27, suppl. 1, 1387 (1978).
W. Hinterberger, C. Cerni, H. Kinast, H. Pointner and K. H. Tragl, Experientia34, 860 (1978).
R. Seif and F. Cuzin, J. Virol.24, 721 (1977).
H. Pointner, G. Hengl and H. Wrba. unpublished observations.
M. R. Enochs and L. R. Johnson, Fedn Proc.36, 1942 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenzhofer, R., Cerni, C., Fröhlich, I. et al. Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitro. Experientia 37, 1015–1017 (1981). https://doi.org/10.1007/BF01971812
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01971812